AI Terminal
Fresenius Medical Care AG & Co. KGaA
Transaction in Own Shares • Mar 2, 2020
165_rns_2020-03-02_323d305b-166b-4d8a-b389-61ec410a7c06.html
Transaction in Own Shares
Open in ViewerOpens in native device viewer
News Details
Other Capital Market Information | 2 March 2020 09:26
Fresenius Medical Care AG & Co. KGaA: Release of a capital market information
Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052
02.03.2020 / 09:26
Dissemination of a Post-admission Duties announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Share buy-back – 37 th Interim Report
In the period from February 24, 2020 until and including February 28, 2020, a total of 5,398 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA (‘Fresenius Medical Care’) announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.
The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange:
| Day of repurchase | Aggregated volume in number of shares | Weighted average share price in EUR |
| 24.02.2020 | 0 | – |
| 25.02.2020 | 0 | – |
| 26.02.2020 | 0 | – |
| 27.02.2020 | 5,398 | 70.5893 |
| 28.02.2020 | 0 | – |
The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including February 28, 2020 therefore amounts to 5,257,395 shares.
Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care’s website at www.freseniusmedicalcare.com under section Investors.
Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board
Bad Homburg v.d.H., March 02, 2020
02.03.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Fresenius Medical Care AG & Co. KGaA |
| Else-Kröner-Straße 1 | |
| 61352 Bad Homburg | |
| Germany | |
| Internet: | www.freseniusmedicalcare.com |
| End of News | DGAP News Service |